Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
Parkinson’s disease (PD) is an age-related neurological disorder characterized by a loss of dopaminergic neurons within the midbrain. Neuroinflammation has been nominated as one of the key pathogenic features of PD. Recently, the inadequate pharmacotherapy and adverse effects of conventional drugs h...
Main Authors: | Sandeep More, Dong-Kug Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6643/9/5/451 |
Similar Items
-
Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death
by: Sandeep Vasant More, et al.
Published: (2017-05-01) -
Microglia and astrocyte dysfunction in parkinson's disease
by: Tae-In Kam, et al.
Published: (2020-10-01) -
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
by: Madiha Rasheed, et al.
Published: (2021-05-01) -
Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
by: Ka Woon Karen Chan, et al.
Published: (2020-01-01) -
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
by: Ghosh Anamitra, et al.
Published: (2012-10-01)